Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Plethysmograph Market size was valued at USD 108.56 million in 2024 and is expected to reach USD 212.44 million by 2037, expanding at around 5.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of plethysmograph is assessed at USD 117.96 million.
The growth of the market can be attributed to the increasing prevalence of chronic respiratory diseases, such as asthma and COPD, as well as the growing demand for accurate diagnosis of respiratory diseases. As of 2019, chronic respiratory diseases accounted for 534,242 deaths in North America, with 50% of deaths occurring in men and 50% in women. The mortality rate among men (42.2 deaths per 100,000) was higher than the mortality rate among women (31.0 deaths per 100,000). Plethysmographs are used to measure the volume of air in the lungs, as well as the amount of oxygen that is inhaled and exhaled. As the prevalence of respiratory diseases increases, the need for more accurate and reliable measurement of air volume and oxygen levels also increases, driving up the market growth.
In addition to these, factors that are believed to fuel the market growth of plethysmographs include growing awareness about health and well-being, increasing prevalence of lifestyle diseases, rising demand for non-invasive and painless diagnostic procedures, Moreover, technological advances in medical devices enable the development of next-generation plethysmographs, which is projected to drive market growth in coming years. For instance, COSMED's Q-Box is an advanced body box designed to accurately measure thoracic gas volume, including static lung volume (TLC, RV, and ITGV) and airway resistance and conductance (RAW and GAW) using complete body plethysmography.
Plethysmograph Sector: Growth Drivers and Challenges
Growth Drivers
-
Rising Popularity of Remote Monitoring Among Patients - According to a survey conducted in 2020, 22 million U.S. patients used remote patient monitoring tools and services. It is expected that 29 million U.S. patients will have access to remote patient monitoring devices and tools by 2024. Remote monitoring allows patients to track their health from the comfort of their homes, using devices such as plethysmographs, which measure blood oxygen levels and respiration rates. This eliminates the need for frequent hospital visits, increasing convenience for the patient and reducing healthcare costs for the provider.
- Continuous Improvement in Healthcare Technology - For instance, wearable photoplethysmography sensors are the latest technological advancements in plethysmographs. This technology has enabled the development of more accurate and reliable devices for measuring human vital signs, such as heart rate and respiration. These devices can be used for medical diagnostics, research, and monitoring of health and fitness.
- Increasing Number of Geriatrics Worldwide - As people age, they are more prone to suffer from respiratory illnesses such as asthma, COPD, and other chronic conditions. Plethysmographs are used to measure the volume of air in and out of the lungs, which helps diagnose these conditions. For instance, In accordance with the World Ageing Report 2019, it is expected that the number of people aged 65 and over will reach 83.813 million by 2050, up from 53.340 million in 2019. With the growing global geriatric population, the demand for plethysmographs is expected to rise.
- Rise in the Number of Tobacco Smoking - According to the World Health Organization, tobacco is responsible for the death of more than 8 million individuals annually. Approximately 22.3% of the world's population smoked in 2020, along with 36.7% of men and 7.8% of women. As more people take up smoking, there is an increasing need for accurate and reliable medical diagnostic devices to monitor respiratory health. Plethysmographs measure changes in the volume of a body part, usually the lungs, and are used to detect abnormalities in lung function.
- Rising Prevalence of Chronic Obstructive Pulmonary Disease (COPD) - COPD is a serious lung condition characterized by difficulty breathing. As COPD becomes more common, diagnostics and treatments are needed. According to statistics released by the World Health Organization, COPD ranks third in mortality worldwide, causing 3.23 million deaths in the year 2019. This has contributed to an increased demand for plethysmographs, which are devices used to diagnose and monitor COPD.
Challenges
-
High cost of plethysmographs and their associated accessories- The high cost of plethysmographs and their associated accessories is due to the expensive components used in the plethysmograph system, such as pressure transducers and amplifiers, which increase the overall cost of the system. Additionally, the cost of calibration and maintenance of the plethysmograph system can also be expensive and is a major factor hindering market expansion.
-
Unawareness regarding the use of plethysmographs in remote areas
- Lack of trained professionals to operate the equipment
Plethysmograph Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.3% |
|
Base Year Market Size (2024) |
USD 108.56 million |
|
Forecast Year Market Size (2037) |
USD 212.44 million |
|
Regional Scope |
|
Plethysmograph Segmentation
End-user (Hospitals, Clinics)
The global plethysmograph market is segmented and analyzed for demand and supply by end use into hospitals, clinics, and others. Out of these, the hospital segment is estimated to gain the largest market share of about 45% in the year 2037. The growth of the segment can be attributed to the rising number of hospital-based procedures, the increasing prevalence of chronic diseases, and technological advancements in plethysmograph devices are some of the factors driving the growth of the hospital segment. Additionally, government initiatives to promote the use of medical devices in healthcare facilities is further augmenting the market growth. For instance, the Government of India has initiated a program known as the National Health Mission, which is designed to provide free diagnostic services in hospitals with the help of noninvasive and low-cost tools to improve patients’ clinical outcomes.
Type (Body, Limbs)
The global market is segmented and analyzed for demand and supply by type into body plethysmograph, limb plethysmograph, and others. Out of these, the limb plethysmograph segment is estimated to gain a significant market share of about 38% in the year 2037. The growth of the segment can be attributed to the increasing prevalence of chronic illnesses such as hypertension and diabetes, which require frequent monitoring of limb volume. The limb plethysmograph is a non-invasive device that can measure the amount of blood flow in the limbs, which is important for monitoring hypertension and diabetes. Additionally, advancements in technology have made plethysmographs more accurate and user-friendly, and market players are launching products with these features, which is boosting the demand for plethysmographs.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By End Use |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportPlethysmograph Market Industry - Regional Synopsis
North American Market Forecast
North America industry is likely to account for largest revenue share of 35% by 2037. The growth of the market can be attributed majorly to the increasing awareness of the importance of preventive healthcare, and rising incidences of lung diseases such as asthma. According to the Asthma and Allergy Foundation of America, in the U.S., nearly 26 million people suffer from asthma and nearly 21 million Americans ages 18 and older suffer from asthma. In 2020, approximately 52.9% of children under the age of 5 suffering from asthma had an asthma attack. Asthma is a chronic lung disease that causes breathing difficulties and wheezing. The use of a plethysmograph allows doctors to measure the amount of air that a person can breathe in and out, which is helpful in diagnosing and monitoring asthma. In addition, advancements in connected healthcare technologies and the growing adoption of digital health solutions along with increasing demand for remote patient monitoring among regional populations are also driving the growth of the market in North America.
APAC Market Statistics
The Asia Pacific plethysmograph market is estimated to be the second largest, registering a share of about ~27% by the end of 2037. The growth of the market can be attributed majorly to the rising demand for ambulatory monitoring systems and the increasing prevalence of obesity as a result of sedentary lifestyles among the regional population. Obesity can contribute to a number of health issues such as cardiovascular diseases and respiratory problems, which in turn increases the demand for medical care and monitoring. Plethysmographs are used to monitor pulmonary function and are therefore in high demand in the Asia Pacific region attributable to the rising number of obese individuals. Additionally, increasing awareness about the advantages of plethysmograph testing and the availability of cost-effective plethysmograph systems in the region are also expected to drive market growth in the region.
Europe Market Forecast
Further, the plethysmograph market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2037. The growth of the market can be attributed majorly to the rising awareness about the benefits of the plethysmograph, the growing demand for technologically advanced medical devices, and the increasing demand for non-invasive diagnostic procedures. The growing number of people addicted to liquor and Smoking is also contributing to product demand in the region. Alcohol and smoking damage the lungs, making them more vulnerable to infection and diseases. This increases the need for accurate and reliable diagnostic tools, such as plethysmographs, to detect and diagnose respiratory problems.
Companies Dominating Plethysmograph the Landscape
- SCIREQ
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Vyaire Medical
- ACI Medical LLC
- BioTekna Srl
- D. E. Hokanson Inc.
- Geratherm Medical AG
- medical equipment Europe GmbH,
- Medizinische Messtechnik GmbH
- MGC Diagnostics Corp.
- Piston Ltd.
In the News
- An innovative portable plethysmograph, the Pneupac Solo PV2, was introduced by Vyaire Medical. The device is designed to measure the volume of air that is inhaled and exhaled, making it easier for doctors to diagnose and monitor asthma and other respiratory conditions. It is also designed to be lightweight and portable, making it easy to use in the home or on the go.
- A new SCIREQ product, the vivoFlow - WBP (Whole Body Plethysmograph Chamber), was unveiled at the Experimental Biology Meeting. As well as being fully compatible with current systems, the vivoFlow has a number of design features that both improve the quality of data and make it easier to use.
Author Credits: Radhika Pawar
- Report ID: 4878
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT
